Search for: "Amyris Inc" Results 1 - 12 of 12
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Aug 2011, 3:45 pm by Lawrence B. Ebert
A key sentence in a WSJ post on biofuels companies with recent IPOs: But most of the stocks have been battered since July amid the volatile market, and only Amyris Inc., the other of last year's biofuel offerings, closed above its IPO price Friday [26 Aug 11]. [read post]
8 Feb 2011, 2:46 pm by Lawrence B. Ebert
(And they can have this slogan -- Amyris Encounters -- for free.) [read post]
17 Nov 2023, 3:34 pm by John Stigi and John Mysliwiec
 The derivative suit, brought by shareholders of Amyris, Inc., alleges that Doerr and several others, through Foris, obtained short-swing profits from the sale of Amyris securities by reason of these board-approved transactions. [read post]
14 Sep 2020, 8:14 am by Leiza Dolghih
Most recently, a New York-based biosynthetic cannabinoid developer Lavvan Inc., sued a biotech company, Amyris, for $881 millions, asserting a claim for trade secrets misappropriation and patent infringement. [read post]
27 Nov 2010, 9:15 am by Lawrence B. Ebert
“We have to have a target and we need to stick with it,” said Andy Foster, president and chief operating officer of AE Biofuels Inc. [read post]
23 Apr 2015, 2:43 pm
To address this problem, a public-private partnership to create synthetic artemisinin was formed in 2004 by PATH, the University of California Berkeley (a 2013 Patents for Humanity award winner), and Amyris, Inc., with support from the Bill & Melinda Gates Foundation. [read post]
25 Apr 2008, 6:37 am
Another issue is (at least the perception) that the University is too risk-adverse: Deals must pass “the Chronicle test,” said Jack Newman, a UC Berkeley graduate and now senior vice president of research at Amyris Biotechnologies Inc. in Emeryville. [read post]